Tuesday, July 1, 2025 11:07 PM

Tag: Ovid Therapeutics

Ovid Therapeutics Inc. ($OVID) Finalizes Deal to Sell Ganaxolone Royalties Outside China for $7M

Staff Writer -
Ovid Therapeutics Inc. (OVID) has entered into a definitive agreement with Immedica Pharma AB for the sale of its future royalties related to ganaxolone...
Our platform offers actionable news and data on events that could sway financial markets. At Catalyst DAILY, we monitor a wide variety of market catalysts, which are essential events or announcements that can trigger significant price movements in stocks, currencies, or entire sectors.

OUR WEBSITE STRICTLY PROHIBITS ANY FORM OF PROMOTION OR TOUTING
Contact us: info@catalystdaily.com
© Catalyst Daily 2025